MultiCell Technologies Inc (MCET)

[TPX]

Hepatitis C Market Pipeline Revive H1 Therapeutics, 2018 Stage of Development, Companies and Product Description

June 7, 2018

Hepatitis C Market – Pipeline Therapeutics H1 2018 Review, with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players of Hepatitis C Market such as AbbVie Inc, Achillion Pharmaceuticals Inc, AIMM Therapeutics BV, Akshaya Bio Inc, Amarillo Biosciences Inc, Amarna Therapeutics BV, ARA Healthcare Pvt Ltd, Beijing Kawin Technology Share-Holding Co Ltd, Beta Pharma Inc, Biotest Pharmaceuticals Corp, Biotron Ltd, Boehringer Ingelheim GmbH, Bolder Biotechnology Inc, Bristol-Myers Squibb Co, Cocrystal Pharma Inc, ContraVir Pharmaceuticals Inc, DEKK-TEC Inc, Ennaid Therapeutics LLC, F. Hoffmann-La Roche Ltd, Galactica Biotech Ltd, Genecode AS, GeneCure LLC, Genoscience Pharma, Gilead Sciences Inc, GinkgoPharma Co Ltd, GlaxoSmithKline Plc, ImmunoBiology Ltd, Immunotope Inc, Inovio Pharmaceuticals Inc, Integrated BioTherapeutics Inc, Johnson & Johnson, Karyopharm Therapeutics Inc, Kineta Inc, Medivir AB, Merck & Co Inc, Microbio Co Ltd, MultiCell Technologies Inc, Novalex Therapeutics Inc, Novartis AG, NovaTarg Therapeutics Inc, Ono Pharmaceutical Co Ltd, Pfenex Inc, Pfizer Inc, PharmaEssentia Corp, Presidio Pharmaceuticals Inc, Profectus BioSciences Inc, Regulus Therapeutics Inc, Replicor Inc, Rodos BioTarget GmbH, SomaGenics Inc, Sudershan Biotech Ltd, TaiGen Biotechnology Co Ltd, TaiwanJ Pharmaceuticals Co Ltd, Therapure Biopharma Inc, THEVAX Genetics Vaccine USA Inc, Toray Industries Inc, Vakzine Projekt Management GmbH, Vaxart Inc, Vectorite Biomedical Inc, Vertex Pharmaceuticals Inc, WhanIn Pharmaceutical Co Ltd, Zylacta Corp and Other

https://businessinvestor24.com/123359/hepatitis-c-market-pipeline-revive-h1-therapeutics-2018-stage-of-development-companies-and-product-description/